LOUISVILLE, Ky. – UofL Health is the first health system in Kentucky to treat a patient with histotripsy, a novel technology that uses ultrasound energy to precisely destroy liver tumors in a single outpatient procedure. Histotripsy is delivered using the new Edison® Histotripsy System, an image guided sonic beam therapy that uses proprietary technology and advanced imaging to deliver noninvasive, personalized treatments with precision and control.
“We are so pleased to be the first and only provider in Kentucky to offer this treatment option for our patients with liver tumors,” said Charles Scoggins, M.D., surgical oncologist with UofL Health. “Histotripsy provides us with a noninvasive, outpatient method to treat liver tumors or to combine with other liver treatment options in order to give our patients the best clinical outcomes possible.”
Histotripsy uses the power of micro-bubbles to destroy targeted tissues and avoids ionizing energy of radiation, heat damage from thermal technologies, and incisions or needles from traditional treatments. Doctors and researchers have studied histotripsy for more than 20 years, including in multi-national clinical trials. In recent clinical studies conducted in Europe, the U.K. and U.S., histotripsy has been used successfully in humans to destroy primary and metastatic liver tumors.
UofL Health – UofL Hospital is currently one of only 89 hospitals worldwide with this exciting new treatment option. Bringing this revolutionary technology into the UofL Health liver treatment portfolio further demonstrates the hospital’s commitment to offering cutting-edge treatment options to the patients it serves.
For more information on the Edison procedure at UofL Hospital, to see if you may qualify for the procedure or to refer a patient visit: UofL Physicians – Surgical Oncology or call 502-583-8303.
